Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents
HM Zhou, JG Zhang, X Zhang, Q Li - Signal transduction and targeted …, 2021 - nature.com
Cancer stem cells (CSCs) show a self-renewal capacity and differentiation potential that
contribute to tumor progression and therapy resistance. However, the underlying processes …
contribute to tumor progression and therapy resistance. However, the underlying processes …
[HTML][HTML] Stem cell programs in cancer initiation, progression, and therapy resistance
Over the past few decades, substantial evidence has convincingly revealed the existence of
cancer stem cells (CSCs) as a minor subpopulation in cancers, contributing to an aberrantly …
cancer stem cells (CSCs) as a minor subpopulation in cancers, contributing to an aberrantly …
NF-κB, inflammation, immunity and cancer: coming of age
K Taniguchi, M Karin - Nature Reviews Immunology, 2018 - nature.com
Fourteen years have passed since nuclear factor-κB (NF-κB) was first shown to serve as a
molecular lynchpin that links persistent infections and chronic inflammation to increased …
molecular lynchpin that links persistent infections and chronic inflammation to increased …
Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
Amplification of epidermal growth factor receptor (EGFR) and its active mutant EGFRvIII
occurs frequently in glioblastoma (GBM). While EGFR and EGFRvIII play critical roles in …
occurs frequently in glioblastoma (GBM). While EGFR and EGFRvIII play critical roles in …
Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
Y Komohara, Y Fujiwara, K Ohnishi… - Advanced drug delivery …, 2016 - Elsevier
The macrophage is known to be a multifunctional antigen presenting cells and playing a
central role in inflammation. Macrophages infiltrate into malignant tumor tissues in high …
central role in inflammation. Macrophages infiltrate into malignant tumor tissues in high …
Cancer stem cells and chemoresistance: The smartest survives the raid
J Zhao - Pharmacology & therapeutics, 2016 - Elsevier
Chemoresistant metastatic relapse of minimal residual disease plays a significant role for
poor prognosis of cancer. Growing evidence supports a critical role of cancer stem cell …
poor prognosis of cancer. Growing evidence supports a critical role of cancer stem cell …
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
K Taniguchi, M Karin - Seminars in immunology, 2014 - Elsevier
Inflammatory responses play pivotal roles in cancer development, including tumor initiation,
promotion, progression, and metastasis. Cytokines are now recognized as important …
promotion, progression, and metastasis. Cytokines are now recognized as important …
IL-6: the link between inflammation, immunity and breast cancer
J Chen, Y Wei, W Yang, Q Huang, Y Chen… - Frontiers in …, 2022 - frontiersin.org
Breast cancer is one of the leading causes of mortality in females. Over the past decades,
intensive efforts have been made to uncover the pathogenesis of breast cancer. Interleukin …
intensive efforts have been made to uncover the pathogenesis of breast cancer. Interleukin …
Paneth cell multipotency induced by notch activation following injury
Paneth cells are post-mitotic intestinal epithelial cells supporting the stem cell niche and
mucosal immunity. Paneth cell pathologies are observed in various gastrointestinal …
mucosal immunity. Paneth cell pathologies are observed in various gastrointestinal …
Suppression of cancer relapse and metastasis by inhibiting cancer stemness
Y Li, HA Rogoff, S Keates, Y Gao… - Proceedings of the …, 2015 - National Acad Sciences
Partial or even complete cancer regression can be achieved in some patients with current
cancer treatments. However, such initial responses are almost always followed by relapse …
cancer treatments. However, such initial responses are almost always followed by relapse …